{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:21:44Z","timestamp":1790889704776,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1067\/mhj.2002.126733","type":"journal-article","created":{"date-parts":[[2003,1,10]],"date-time":"2003-01-10T18:38:55Z","timestamp":1042223935000},"page":"1065-1073","source":"Crossref","is-referenced-by-count":90,"title":["Effect of fenfluramine-derivative diet pills on cardiac valves: A meta-analysis of observational studies"],"prefix":"10.1067","volume":"144","author":[{"given":"Molly","family":"Sachdev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Jollis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mhj.2002.126733_bib1","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/jama.282.16.1530","article-title":"Annual deaths attributable to obesity in the United States","volume":"282","author":"Allison","year":"1999","journal-title":"JAMA"},{"key":"10.1067\/mhj.2002.126733_bib2","first-page":"B8","article-title":"Critics claim diet clinics misuse obesity drugs","author":"Langreth","year":"1997","journal-title":"Wall Street Journal"},{"key":"10.1067\/mhj.2002.126733_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126733_NEWBIB1","unstructured":"Reference deleted."},{"key":"10.1067\/mhj.2002.126733_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0735-1097(99)00321-6","article-title":"Low prevalence of valvular heart disease in 226 phentermine-fenfluramine protocol subjects prospectively followed for up to 30 months","volume":"34","author":"Burger","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.126733_bib6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1001\/jama.283.13.1703","article-title":"Valvular abnormalities and cardiovascular status following exposure to dexfenfluramine or phentermine\/fenfluramine","volume":"283","author":"Gardin","year":"2000","journal-title":"JAMA"},{"key":"10.1067\/mhj.2002.126733_bib7","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.4065\/74.12.1191","article-title":"Echocardiographic improvement of use of fenfluramine and phentermine","volume":"74","author":"Hensrud","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1067\/mhj.2002.126733_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJM199809103391102","article-title":"A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation","volume":"339","author":"Jick","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126733_bib9","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1161\/01.CIR.101.17.2071","article-title":"Fenfluramine and phentermine and cardiovascular findings: the effect of treatment duration on prevalence of valve abnormalities","volume":"101","author":"Jollis","year":"2000","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126733_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1056\/NEJM199809103391101","article-title":"The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drugs","volume":"339","author":"Khan","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126733_bib11","first-page":"I-645","article-title":"Fen-Phen use is not associated with an increased prevalence of significant valvular heart disease [abstract]","volume":"98","author":"Lopez-Jimenez","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126733_bib12","first-page":"510","article-title":"Are dexfenfluramine, fenfluramine, and phentermine associated with valvular heart disease? blinded analysis of 107 patients with matched controls [abstract]","volume":"11","author":"Rosen","year":"1998","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1067\/mhj.2002.126733_bib13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1161\/01.CIR.100.21.2161","article-title":"Prevalence and determinants of valvulopathy in patients treated with dexfenfluramine","volume":"100","author":"Shively","year":"1999","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126733_bib14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJM199809103391103","article-title":"An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group","volume":"339","author":"Weissman","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mhj.2002.126733_bib15","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/S0735-1097(99)00445-3","article-title":"Prevalence of valvular-regurgitation associated with dexfenfluramine three to five months after discontinuation of treatment","volume":"34","author":"Weissman","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.126733_bib16","first-page":"1061","article-title":"Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: US Department of Health and Human Services Interim Public Health Recommendations, November 1997","volume":"46","author":"Bowen","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1067\/mhj.2002.126733_bib17","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.98.18.1949","volume":"98","author":"Bonow","year":"1998","journal-title":"Circulation"},{"key":"10.1067\/mhj.2002.126733_bib18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-134-4-200102200-00008","article-title":"The progression of fenfluramine-associated valvular heart disease assessed by echocardiography","volume":"134","author":"Mast","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1067\/mhj.2002.126733_bib19","first-page":"1159","article-title":"Fen\/Phen and valvular heart disease: if it sounds too bad to be true, perhaps it isn't","volume":"34","author":"Schiller","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.126733_bib20","first-page":"549A","article-title":"Transesophageal echocardiography in phen-fen users suggests frequent misdiagnosis of valvular heart disease by TTE [abstract]","volume":"33","author":"Roldan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1067\/mhj.2002.126733_bib21","first-page":"324","article-title":"The clinical dilemma of anorectic drug use and valvular heart disease","volume":"84","author":"Grayburn","year":"1999","journal-title":"Am J Cardiol"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302002326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870302002326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T16:28:43Z","timestamp":1554049723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870302002326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["S0002870302002326"],"URL":"https:\/\/doi.org\/10.1067\/mhj.2002.126733","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}